Welcome

The Canadian Antimicrobial Resistance Alliance (CARA) launched a website in early 2007, CAN-R (www.can-r.ca). The site is an online research portal designed to aid and educate Canadian healthcare providers on the escalating issue of antimicrobial resistance in Canada.

Providing current and comprehensive information, the site includes a variety of features and tools on antimicrobial resistance in Canada including:

Surveillance of pathogens and infections from our national CANWARD study
Surveillance of antimicrobial resistance in CANWARD
Surveillance of S. pneumoniae antimicrobial resistance in SAVE
Antimicrobial usage data
Activity of investigational and new antimicrobials
Current research presented at major conferences
Key publications from evidence-based medical literature
Videos: antimicrobial mechanisms of action and resistance (see EDUCATION)

Who will benefit from CAN-R

CAN-R is a useful tool for researchers, medical care providers, and the media in understanding the rise of antimicrobial resistance in Canada and how it is being managed.

CANWARD

In 2007, CARA initiated the CANWARD study. CANWARD is a national, annual, CARA/ National Microbiology Laboratory - Public Health Agency of Canada-partnered surveillance study assessing pathogens causing patient infections in Canadian hospitals and their antimicrobial resistance patterns.

SAVE

In 2011, CARA, the University of Manitoba, and the National Microbiology Laboratory-Public Health Agency of Canada began a collaboration to assess changes in antimicrobial resistance patterns of S. pneumoniae serotypes annually, as part of the SAVE (Streptococcus pneumoniae Serotyping and Antimicrobial Susceptibility: Assessment for Vaccine Efficacy in Canada After the Introduction of PCV-13) study.